Key facts
- It has raised $10.0M; the latest was Early Stage VC ($10.0M) in Dec 2024.
- Notable investors include Lux Capital, Menlo Ventures, Elad Gil, Electric Capital, Qasar Younis — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Bluenote AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Bluenote AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bluenote AI
Developer of a life sciences AI Platform designed to accelerate innovation with AI and improve document quality. The company's platform is built for and trusted by leading life sciences companies, enabling customers to automate copy-pasting and synthesis tasks and improve document quality for CSRs, CMC documents, AV reports, ICFs, and more.
- Sector
- Information Technology
- HQ
- San Francisco, CA, United States
- Founded
- 2022
- Employees
- 14
- Website
- bluenote.ai/
- Ownership
- Privately Held (backing)
Bluenote AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bluenote AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bluenote AI in its N-PORT filings yet. We sweep new filings monthly.